Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of REL-1017 (d-Methadone)

NCT03638869 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Neuropathic Pain

Interventions

DRUG: REL-1017
DRUG: Placebo

Sponsor

Relmada Therapeutics, Inc.